Positron Emission Tomography/Computed Tomography in the Management of Hodgkin's Disease and Non-Hodgkin's Lymphoma

被引：10

作者：

Rodriguez-Vigil, Beatriz ^{[1
]}

Gomez-Leon, Nieves ^{[1
]}

Pinilla, Inmaculada ^{[1
]}

Hernandez-Maraver, Dolores ^{[2
]}

Coya, Juan ^{[3
]}

Martin-Curto, Luis ^{[3
]}

机构：

[1] Univ Hosp La Paz, Dept Radiol, Paseo Castellana 261, Madrid 28046, Spain

[2] Univ Hosp La Paz, Dept Haematol, Madrid, Spain

[3] Univ Hosp La Paz, Dept Nucl Med, Madrid, Spain

来源：

CURRENT PROBLEMS IN DIAGNOSTIC RADIOLOGY | 2006年 / 35卷 / 04期

关键词：

D O I：

10.1067/j.cpradiol.2006.02.001

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

The incidence of Hodgkin's disease (HD) and Non-Hodgkin's lymphoma (NHL) is around 8% of all malignancies. Fortunately, HD and NHL are among the few malignancies that are potentially curable with current existing treatment modalities, even in advanced or recurrent disease. Accurate staging, early therapy monitoring, and posttreatment evaluation of lymphomas are important for optimum management of these patients. We reviewed the imaging findings of patients with histologically proved lymphoma who underwent staging positron emission tomography/computed tomography (PET/CT), early monitoring therapy PET/CT (after 3 cycles of chemotherapy), and posttreatment PET/CT. PET/CT imaging findings are shown. Utility of PET/CT in recognizing false-positive and falsenegative cases of CT and PET alone is addressed. Pitfalls and diagnostic difficulties are analyzed. PET/CT is a new imaging technology that improves the evaluation of lymphoma. This review will help the reader to better understand the imaging findings and applications of PET/CT in the management of lymphoma.

引用

页码：151 / 163

页数：13

共 47 条

[21] PET-CT image co-registration in the thorax: influence of respiration [J].

Goerres, GW ;

Kamel, E ;

Heidelberg, TNH ;

Schwitter, MR ;

Burger, C ;

von Schulthess, GK .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (03) :351-360

[22] [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma:: an early prognostic tool for predicting patient outcome [J].

Haioun, C ;

Itti, E ;

Rahmouni, A ;

Brice, P ;

Rain, JD ;

Belhadj, K ;

Gaulard, P ;

Garderet, L ;

Lepage, E ;

Reyes, F ;

Meignan, M .

BLOOD, 2005, 106 (04) :1376-1381

[23] PET diagnostic accuracy: Improvement with in-line PET-CT system: Initial results [J].

Hany, TF ;

Steinert, HC ;

Goerres, GW ;

Buck, A ;

von Schulthess, GK .

RADIOLOGY, 2002, 225 (02) :575-581

[24]

Hoskin PJ, 2003, EUR J NUCL MED MOL I, V30, P128

[25]

Israel O, 2002, J NUCL MED, V43, P1129

[26] Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease [J].

Jerusalem, G ;

Beguin, Y ;

Fassotte, MF ;

Belhocine, T ;

Hustinx, R ;

Rigo, P ;

Fillet, G .

ANNALS OF ONCOLOGY, 2003, 14 (01) :123-130

[27] An introduction to PET-CT imaging [J].

Kapoor, V ;

McCook, BM ;

Torok, FS .

RADIOGRAPHICS, 2004, 24 (02) :523-543

[28] Staging and classification of lymphoma [J].

Lu, P .

SEMINARS IN NUCLEAR MEDICINE, 2005, 35 (03) :160-164

[29] Positron emission tomography/computed tomography Imaging for the detection of recurrent ovarian and fallopian tube carcinoma: A retrospective review [J].

Makhija, S ;

Howden, N ;

Edwards, R ;

Kelley, J ;

Townsend, DW ;

Meltzer, CC .

GYNECOLOGIC ONCOLOGY, 2002, 85 (01) :53-58

[30] 18-F-fluorodeoxyglucose positron emission tomography as a new approach to detect lymphomatous bone marrow [J].

Moog, F ;

Bangerter, M ;

Kotzerke, J ;

Guhlmann, A ;

Frickhofen, N ;

Reske, SN .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) :603-609

← 1 2 3 4 5 →